Literature DB >> 25823647

Radiation protection in cardiovascular interventions: what can we do?

Qiang Liu1, Qinghua Wu.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25823647      PMCID: PMC5588223          DOI: 10.1159/000380911

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


× No keyword cloud information.
Dear Editor, Over the last 20 years, interventional technology has expanded significantly, both in the field of diagnosis and therapy. Because of the obvious benefits to patients, most of these interventions are performed under fluoroscopic guidance. Interventional cardiologists who operate the X-ray unit during fluoroscopically guided procedures are required to be present in the room and are routinely and chronically exposed to ionizing radiations [1]. A strong body of evidence has shown that interventional cardiologists receive the highest radiation dose among all other medical staff exposed to X-rays [2,3]. Furthermore, reports have revealed that such exposure could be a risk of malignancy and skin injury for interventional cardiologists [4,5], which creates a major public health burden. From the public health perspective, the issue of occupational radiation protection is important. Therefore, any effort to optimize radiation safety is strongly encouraged. Recently, at the American Heart Association (AHA) 2014 Scientific Sessions, a prospective randomized trial by Christopoulos et al. [6] showed that interventional cardiologists who wore a novel radiation-monitoring device were able to decrease their radiation exposure by one third. Overall, the fluoroscopically guided procedures lasted a median of 27 min. Diagnostic angiography lasts a median of 17 min and percutaneous coronary intervention lasts a median of 42 min [6]. The Bleeper device produces a ‘bleep’ sound every 15 min in response to normal background radiation. By using the radiation-monitoring device, operators closest to the patient (first operators) were able to lessen their radiation exposure by 36s%, while assistants who were farther from the patient (second operators) were able to lessen their radiation exposure by 29s% [6]. Furthermore, the authors identified which factors predicted a high operator radiation exposure during cardiac catheterization. The results showed that radial access and chronic total occlusion interventions were associated with a high first operator radiation exposure. The pooled estimate of multivariate ORs was 6.62 (95s% CI: 3.13–14.76) and 5.53 (95s% CI: 1.73–20.71). However, real-time radiation monitoring and the use of a radioabsorbent drape modestly decreased the risk of first operator radiation exposure. The pooled estimate of multivariate ORs was 0.33 (95s% CI: 0.19–0.57) and 0.38 (95s% CI: 0.18–0.77). Prior studies revealed that the transradial approach was associated with a higher radiation dose absorbed by interventional cardiologists [7,8]. This was probably related to the more complicated catheter manipulation requiring a prolonged fluoroscopic time and a less favorable operator position closer to the X-ray source, especially for less skilled operators [9]. In spite of this, the magnitude of the radiation absorbed by operators applying the radial approach is still unclear. A further randomization study for the radial approach is required to compare transfemoral, right transradial and left transradial access. What can we do for occupational radiation protection? The following recommendations should be considered: (a) faster and safer radiation detection devices are necessary to identify instant and cumulative radiation doses during a certain procedure; (b) large prospective randomized trials are needed to explore which radial approach is associated with lower radiation doses absorbed by interventional cardiologists, and (c) as the European Society of Cardiology Association (ESCA) suggested, interventional cardiologists should practice a key principle of radiation protection that ‘each patient should get the right imaging examination, at the right time, with the right radiation dose’ [10].
  10 in total

Review 1.  Occupational radiation doses to operators performing fluoroscopically-guided procedures.

Authors:  Kwang Pyo Kim; Donald L Miller; Amy Berrington de Gonzalez; Stephen Balter; Ruth A Kleinerman; Evgenia Ostroumova; Steven L Simon; Martha S Linet
Journal:  Health Phys       Date:  2012-07       Impact factor: 1.316

Review 2.  Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials.

Authors:  Sanjit S Jolly; Shoaib Amlani; Martial Hamon; Salim Yusuf; Shamir R Mehta
Journal:  Am Heart J       Date:  2008-11-01       Impact factor: 4.749

3.  Evaluation of the impact of a system for real-time visualisation of occupational radiation dose rate during fluoroscopically guided procedures.

Authors:  V Sandblom; T Mai; A Almén; H Rystedt; Å Cederblad; M Båth; C Lundh
Journal:  J Radiol Prot       Date:  2013-09       Impact factor: 1.394

Review 4.  Brain tumours among interventional cardiologists: a cause for alarm? Report of four new cases from two cities and a review of the literature.

Authors:  Ariel Roguin; Jacob Goldstein; Olivier Bar
Journal:  EuroIntervention       Date:  2012-01       Impact factor: 6.534

5.  Effect of a real-time radiation monitoring device on operator radiation exposure during cardiac catheterization: the radiation reduction during cardiac catheterization using real-time monitoring study.

Authors:  Georgios Christopoulos; Aristotelis C Papayannis; Mohammed Alomar; Anna Kotsia; Tesfaldet T Michael; Bavana V Rangan; Michele Roesle; Deborah Shorrock; Lorenza Makke; Ronald Layne; Rebecca Grabarkewitz; Donald Haagen; Spyros Maragkoudakis; Atif Mohammad; Karan Sarode; Daisha J Cipher; Charles E Chambers; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Circ Cardiovasc Interv       Date:  2014-11-25       Impact factor: 6.546

6.  The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions.

Authors:  Sunil V Rao; Mauricio G Cohen; David E Kandzari; Olivier F Bertrand; Ian C Gilchrist
Journal:  J Am Coll Cardiol       Date:  2010-05-18       Impact factor: 24.094

7.  Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights from the National Research Council's Biological Effects of Ionizing Radiation VII Report.

Authors:  Lucia Venneri; Francesco Rossi; Nicoletta Botto; Maria Grazia Andreassi; Nicoletta Salcone; Ahmed Emad; Mauro Lazzeri; Cesare Gori; Eliseo Vano; Eugenio Picano
Journal:  Am Heart J       Date:  2009-01       Impact factor: 4.749

8.  Randomized comparison of operator radiation exposure comparing transradial and transfemoral approach for percutaneous coronary procedures: rationale and design of the minimizing adverse haemorrhagic events by TRansradial access site and systemic implementation of angioX - RAdiation Dose study (RAD-MATRIX).

Authors:  Alessandro Sciahbasi; Paolo Calabrò; Alessandro Sarandrea; Stefano Rigattieri; Francesco Tomassini; Gennaro Sardella; Dennis Zavalloni; Bernardo Cortese; Ugo Limbruno; Matteo Tebaldi; Andrea Gagnor; Paolo Rubartelli; Antonio Zingarelli; Marco Valgimigli
Journal:  Cardiovasc Revasc Med       Date:  2014-03-26

9.  Radiation exposure to patients and operators during diagnostic catheterization and coronary angioplasty.

Authors:  M Zorzetto; G Bernardi; G Morocutti; A Fontanelli
Journal:  Cathet Cardiovasc Diagn       Date:  1997-04

Review 10.  The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology.

Authors:  Eugenio Picano; Eliseo Vañó; Madan M Rehani; Alberto Cuocolo; Lluis Mont; Vicente Bodi; Olivier Bar; Carlo Maccia; Luc Pierard; Rosa Sicari; Sven Plein; Heiko Mahrholdt; Patrizio Lancellotti; Juhani Knuuti; Hein Heidbuchel; Carlo Di Mario; Luigi P Badano
Journal:  Eur Heart J       Date:  2014-01-08       Impact factor: 29.983

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.